We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Beneficial effects of melatonin in experimental models of Alzheimer disease.
- Authors
Yong Cheng; Zheng Feng; Qing-zhu Zhang; Jun-Tian Zhang
- Abstract
Alzheimer's disease (AD), a progressive degenerative disorder, is characterized by the presence of amyloid deposits, neurofibrillary tangles and neuron loss. Emerging evidence indicates that antioxidants could be useful either for the prevention or treatment of AD. It has been shown that melatonin is a potent antioxidant and free radical scavenger. Additionally, melatonin stimulates several antioxidative enzymes and improves mitochondrial energy metabolism. These findings led us to study amyloid precursor protein transgenic mice, ovariectomized rats, and pheochromocytoma and astroglioma cell lines, to observe whether melatonin had any effect on Alzheimer's symptoms or pathological changes. We found that melatonin had many beneficial effects in experimental models of AD, including improvement of cognitive function, anti-oxidative injury, anti-apoptosis, inhibition of β-amyloid (Aβ) deposition and Aβ fiber formation. Several groups have shown that melatonin has an inhibitory effect on tau protein hyperphosphorylation. These actions may potentially slow down or stop the progression of dementia.
- Publication
Acta Pharmacologica Sinica, 2006, Vol 27, Issue 2, p129
- ISSN
1671-4083
- Publication type
Academic Journal
- DOI
10.1111/j.1745-7254.2006.00267.x